• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于分析药物相互作用的三维模型。

A three-dimensional model to analyze drug-drug interactions.

作者信息

Prichard M N, Shipman C

机构信息

Department of Microbiology and Immunology, School of Medicine, University of Michigan, Ann Arbor 48109-1078.

出版信息

Antiviral Res. 1990 Oct-Nov;14(4-5):181-205. doi: 10.1016/0166-3542(90)90001-n.

DOI:10.1016/0166-3542(90)90001-n
PMID:2088205
Abstract

Nearly four generations of investigators have studied combined drug effects. Their methods of generating and analyzing data have changed dramatically over the years but the basic problem has not. This review examines the inherent difficulties in analyzing combined drug effects and evaluates modern methods of describing these interactions. Researchers have traditionally used two-dimensional (2-D) methods to approximate the actual three-dimensional (3-D) nature of drug interactions. We conclude that these 2-D methods are often inadequate when used to analyze synergistic and antagonistic drug interactions in antiviral and anticancer chemotherapy. We propose a direct and pragmatic 3-D approach to the problem, made possible by microcomputers and sophisticated graphics programs. This procedure directly elucidates the shape of the dose-response surface, identifies the regions of statistically significant synergy and antagonism, and quantitates these effects. It also greatly simplifies the problem since a 3-D surface presents complete drug interactions in a way that can be easily interpreted. We will show that understanding the shape of the resulting 3-D surface is essential to an understanding of complex drug interactions. This new method facilitates the rigorous analysis of drug-drug interactions and offers investigators powerful new tools to analyze combinations of antiviral and anticancer drugs.

摘要

近四代研究人员都在研究联合用药的效果。多年来,他们生成和分析数据的方法发生了巨大变化,但基本问题依然存在。这篇综述探讨了分析联合用药效果时存在的固有困难,并评估了描述这些相互作用的现代方法。传统上,研究人员使用二维(2-D)方法来近似药物相互作用实际的三维(3-D)性质。我们得出结论,当用于分析抗病毒和抗癌化疗中的协同和拮抗药物相互作用时,这些二维方法往往并不充分。我们针对这个问题提出了一种直接且实用的三维方法,借助微型计算机和复杂的图形程序得以实现。这个过程直接阐明了剂量反应表面的形状,确定了具有统计学显著协同和拮抗作用的区域,并对这些效应进行量化。它还极大地简化了问题,因为三维表面以一种易于解释的方式呈现了完整的药物相互作用。我们将表明,理解所得三维表面的形状对于理解复杂的药物相互作用至关重要。这种新方法有助于对药物相互作用进行严谨分析,并为研究人员提供了强大的新工具来分析抗病毒和抗癌药物的组合。

相似文献

1
A three-dimensional model to analyze drug-drug interactions.一种用于分析药物相互作用的三维模型。
Antiviral Res. 1990 Oct-Nov;14(4-5):181-205. doi: 10.1016/0166-3542(90)90001-n.
2
Evaluation of synergism by a novel three-dimensional model for the combined action of cisplatin and etoposide on the growth of a human small-cell lung-cancer cell line, SBC-3.通过一种新型三维模型评估顺铂和依托泊苷联合作用对人小细胞肺癌细胞系SBC - 3生长的协同作用。
Int J Cancer. 1997 May 2;71(3):311-9. doi: 10.1002/(sici)1097-0215(19970502)71:3<311::aid-ijc1>3.0.co;2-0.
3
Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models.评估抗真菌药物对酵母和丝状真菌的体外联合作用:不同药物相互作用模型的比较
Med Mycol. 2005 Mar;43(2):133-52. doi: 10.1080/13693780410001731547.
4
A generalized response surface model with varying relative potency for assessing drug interaction.一种用于评估药物相互作用的具有不同相对效价的广义响应面模型。
Biometrics. 2006 Dec;62(4):986-95. doi: 10.1111/j.1541-0420.2006.00579.x.
5
Evaluation of synergism or antagonism for the combined action of antiviral agents.抗病毒药物联合作用的协同或拮抗作用评估。
Antiviral Res. 1990 Jan;13(1):23-39. doi: 10.1016/0166-3542(90)90042-6.
6
Nonlinear response surface in the study of interaction analysis of three combination drugs.三种联合用药相互作用分析研究中的非线性响应面
Biom J. 2017 Jan;59(1):9-24. doi: 10.1002/bimj.201500021. Epub 2016 May 17.
7
Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics--a comparative study.奥卡西平与传统抗癫痫药物相互作用检测中的等效线图法和阈下刺激法——一项比较研究
Epilepsy Res. 2003 Sep;56(1):27-42. doi: 10.1016/j.eplepsyres.2003.08.003.
8
Analysis of combinations of antiviral drugs and design of effective multidrug therapies.抗病毒药物组合分析与有效多药疗法设计。
Antivir Ther. 1996 Jan;1(1):9-20.
9
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.三联抗真菌药物组合对曲霉菌种的浓度依赖性协同和拮抗作用:采用新的响应面模型进行分析
Antimicrob Agents Chemother. 2007 Jun;51(6):2053-64. doi: 10.1128/AAC.00873-06. Epub 2007 Mar 26.
10
Modeling synergistic effects by using general Hill-type response surfaces describing drug interactions.使用描述药物相互作用的通用 Hill 型响应曲面来模拟协同效应。
Sci Rep. 2022 Jun 22;12(1):10524. doi: 10.1038/s41598-022-13469-7.

引用本文的文献

1
Identification of a small molecule targeting EPLIN as a novel strategy for the treatment of pediatric neuroblastoma and medulloblastoma.鉴定一种靶向EPLIN的小分子作为治疗小儿神经母细胞瘤和髓母细胞瘤的新策略。
Cell Death Dis. 2025 Jul 23;16(1):554. doi: 10.1038/s41419-025-07876-7.
2
First-in-Class Clinically Investigated Oral Factor D Inhibitors for the Treatment of Complement-Mediated Diseases.用于治疗补体介导疾病的首个进入临床研究阶段的口服因子D抑制剂。
Pharm Res. 2025 Jun 25. doi: 10.1007/s11095-025-03882-8.
3
Understanding the Cytomegalovirus Cyclin-Dependent Kinase Ortholog pUL97 as a Multifaceted Regulator and an Antiviral Drug Target.
了解巨细胞病毒周期蛋白依赖性激酶同源物 pUL97 作为一个多方面的调节剂和抗病毒药物靶点。
Cells. 2024 Aug 13;13(16):1338. doi: 10.3390/cells13161338.
4
Antiviral activity of vitamin D derivatives against severe fever with thrombocytopenia syndrome virus in vitro and in vivo.维生素 D 衍生物对体外和体内严重发热伴血小板减少综合征病毒的抗病毒活性。
Virol Sin. 2024 Oct;39(5):802-811. doi: 10.1016/j.virs.2024.08.007. Epub 2024 Aug 20.
5
Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties.鉴定 CXCR4 拮抗剂 TIQ-15 具有双重趋化因子 HIV 进入抑制特性。
PLoS Pathog. 2024 Aug 15;20(8):e1012448. doi: 10.1371/journal.ppat.1012448. eCollection 2024 Aug.
6
No antagonism or cross-resistance and a high barrier to the emergence of resistance for the combination of islatravir and lenacapavir.伊拉瓦病毒和伦卡帕韦联合使用无拮抗或交叉耐药性,耐药性产生的屏障高。
Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0033424. doi: 10.1128/aac.00334-24. Epub 2024 Jun 12.
7
Spectrum of activity and mechanisms of azole-bisphosphonate synergy in pathogenic .唑类-双膦酸盐协同作用在致病. 中的活性谱和机制
Microbiol Spectr. 2024 Jun 4;12(6):e0012124. doi: 10.1128/spectrum.00121-24. Epub 2024 May 2.
8
Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations.重温棋盘法以指导β-内酰胺/β-内酰胺酶抑制剂联合制剂的研发
Antibiotics (Basel). 2024 Apr 7;13(4):337. doi: 10.3390/antibiotics13040337.
9
Proof-of-concept studies with a computationally designed M inhibitor as a synergistic combination regimen alternative to Paxlovid.作为帕罗韦德(Paxlovid)的替代方案,使用计算机设计的 M 抑制剂进行概念验证研究的协同组合方案。
Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2320713121. doi: 10.1073/pnas.2320713121. Epub 2024 Apr 15.
10
Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161.AB-161 的抗乙型肝炎病毒 RNA 稳定剂的临床前抗病毒和安全性特征分析。
Viruses. 2024 Feb 21;16(3):323. doi: 10.3390/v16030323.